Trials / Unknown
UnknownNCT05679089
AssesSment of Early deteCtion basEd oN liquiD Biopsy in Intracranial Tumors
Assessment of Early Detection Based on Liquid Biopsy in Intracranial Tumors: a Prospective Observational Study
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 358 (estimated)
- Sponsor
- Zhujiang Hospital · Academic / Other
- Sex
- All
- Age
- 40 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
ASCEND-BRAIN is a prospective, observational study aimed at early-detection of intracranial tumors by combined assays of cfDNA methylation and other biomarkers. The study will enroll approximately 358 participants including intracranial malignant tumors, patients with benign disorders of central nervous system and healthy participants.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | early detection test | Blood collection and early detection testing |
Timeline
- Start date
- 2022-11-01
- Primary completion
- 2023-12-31
- Completion
- 2024-06-30
- First posted
- 2023-01-10
- Last updated
- 2023-01-10
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05679089. Inclusion in this directory is not an endorsement.